Skip to main content
Johann Gudjonsson, MD, Dermatology, Ann Arbor, MI

Johann Eli Gudjonsson MD


Arthur C. Curtis Professor of Skin Immunology Professor, Dermatology, University of Michigan Medical School

Join to View Full Profile
  • 1500 E Medical Center Dr1st Floor Taubman Ctr Recp BAnn Arbor, MI 48109

  • Phone+1 734-936-4054

Dr. Gudjonsson is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of Michigan
    University of MichiganResidency, Dermatology, 2004 - 2008
  • University of Michigan
    University of MichiganInternship, Internal Medicine, 2003 - 2004
  • University of Iceland
    University of IcelandClass of 1998

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2007 - 2027
  • Dermatology
    American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Fellow (FAAD) American Academy of Dermatology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Dietary Recommendations for Adults with Psoriasis or Psoriatic Arthritis from the Medical Board of the National Psoriasis Foundation  
    Ronald Prussick, Johann E Gudjonsson, Alice Gottlieb, John Koo, Jerry Bagel, Adam R Ford, Joseph A Markenson, Wilson Liao, Joseph F Merola, Jashin J Wu, JAMA

Lectures

  • Skinternal Medicine: An Update on Cutaneous Manifestations of Systemic Disease 
    American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/3/2019

Press Mentions

  • Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients with Systemic Sclerosis and Chronic Pruritus of Unknown Origin
    Galderma Initiates Two New Clinical Trials Investigating Nemolizumab in Patients with Systemic Sclerosis and Chronic Pruritus of Unknown OriginJune 25th, 2025
  • Researchers Uncover Novel Mechanism That Leads to High Blood Pressure
    Researchers Uncover Novel Mechanism That Leads to High Blood PressureJune 12th, 2025
  • VUMC-Michigan Team Awarded NIH Grant to Determine the Cause of Psoriatic Arthritis
    VUMC-Michigan Team Awarded NIH Grant to Determine the Cause of Psoriatic ArthritisMay 13th, 2025
  • Join now to see all

Grant Support

  • University of Michigan MHWFAC CoFar CMC Center ApplicationUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2031
  • University of Michigan MHWFAC CoFar CMC Center ApplicationUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2031
  • Integrated Program for Cutaneous Immune-Stromal Interactions in SLE (IPCISS)UNIVERSITY OF MICHIGAN AT ANN ARBOR2025–2030
  • Immune cell contributions to inflammatory arthritisVANDERBILT UNIVERSITY MEDICAL CENTER2025–2030
  • University of Michigan Skin Biology and Diseases Resource-based CenterUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2029
  • Role of the Hippo pathway in scleroderma pathogenesisUNIVERSITY OF MICHIGAN AT ANN ARBOR2024–2028
  • High performance wearable body odor sensor arrays for disease detection and monitoringUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2027
  • Role of the gender biased transcription factor VGLL3 in promoting autoimmune responses in SLEUNIVERSITY OF MICHIGAN AT ANN ARBOR2017–2027
  • Immunogenomics and Systems Biology CoreUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026
  • ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and SynoviumUNIVERSITY OF ROCHESTER2022–2026

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: